StockData
Molecular Partners AG logo

Molecular Partners AG (MOLN) stock

MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.67−0.19 (-6.82%)

Close on Nov 18, 2026Market cap $107.60MP/E –Yield –

Molecular Partners free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -CHF 51.97M. The highest annual figure on record is CHF 117.39M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CHF 51.97M–
FY2024Dec 31, 2024-CHF 59.95M–
FY2023Dec 31, 2023-CHF 59.58M-150.8%
FY2022Dec 31, 2022CHF 117.39M–
FY2021Dec 31, 2021-CHF 91.89M–
FY2020Dec 31, 2020-CHF 30.43M–
FY2019Dec 31, 2019-CHF 2.22M–

More Molecular Partners figures

See a number that looks wrong?